{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:54:53Z","timestamp":1791320093526,"version":"4.3.1"},"update-to":[{"DOI":"10.1002\/14651858.cd010386","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2014,7,23]],"date-time":"2014-07-23T00:00:00Z","timestamp":1406073600000}}],"reference-count":131,"publisher":"Wiley","issue":"7","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd010386.pub2","type":"journal-article","created":{"date-parts":[[2014,7,23]],"date-time":"2014-07-23T08:11:10Z","timestamp":1406103070000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":62,"title":["<sup>11<\/sup>\n                    C-PIB-PET for the early diagnosis of Alzheimer\u2019s disease dementia and other dementias in people with mild cognitive impairment (MCI)"],"prefix":"10.1002","volume":"2014","author":[{"given":"Shuo","family":"Zhang","sequence":"first","affiliation":[{"name":"China Medical University; Department of Neurology, Shengjing Hospital; 36 Shanhao Street Shenyang Liaoning China 110004"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadja","family":"Smailagic","sequence":"additional","affiliation":[{"name":"University of Cambridge; Institute of Public Health; Forvie Site Robinson Way Cambridge UK CB2 0SR"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Hyde","sequence":"additional","affiliation":[{"name":"University of Exeter Medical School, University of Exeter; Institute of Health Research; Veysey Building Salmon Pool Lane Exeter UK EX2 4SG"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna H","family":"Noel-Storr","sequence":"additional","affiliation":[{"name":"University of Oxford; Radcliffe Department of Medicine; Room 4401c (4th Floor) John Radcliffe Hospital, Headington Oxford UK OX3 9DU"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yemisi","family":"Takwoingi","sequence":"additional","affiliation":[{"name":"University of Birmingham; Public Health, Epidemiology and Biostatistics; Edgbaston Birmingham UK B15 2TT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupert","family":"McShane","sequence":"additional","affiliation":[{"name":"University of Oxford; Radcliffe Department of Medicine; Room 4401c (4th Floor) John Radcliffe Hospital, Headington Oxford UK OX3 9DU"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Feng","sequence":"additional","affiliation":[{"name":"Shengjing Hospital, China Medical University; Department of Neurology; 36 Shanhao Street Shenyang China 110004"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,7,23]]},"reference":[{"key":"10.1002\/14651858.CD010386.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"56","DOI":"10.2174\/156720510790274446","article-title":"High PIB retention in Alzheimer\u2019s disease in early event with complex relationship with CSF biomarkers and functional parameters","volume":"7","author":"Forsberg","year":"2010","journal-title":"Current Alzheimer Research"},{"key":"10.1002\/14651858.CD010386.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.neurobiolaging.2007.03.029","article-title":"PET imaging of amyloid deposition in patients with mild cognitive impairment","volume":"29","author":"Forsberg","year":"2008","journal-title":"Neurobiology of Aging"},{"key":"10.1002\/14651858.CD010386.pub2-BIB0003|cit3","unstructured":"Forsberg A Engler H Blomquist G Almkvist O Hagman G Wall A PET imaging of amyloid depositions in MCI patients using PIB Journal of Cerebral Blood Flow and Metabolism 2007 BO03 01"},{"issue":"1","key":"10.1002\/14651858.CD010386.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s00259-012-2237-2","article-title":"A European multicentre PET study of fibrillar amyloid in Alzheimer's disease","volume":"40","author":"Nordberg","year":"2013","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"key":"10.1002\/14651858.CD010386.pub2-BIB0005|cit5","first-page":"82","article-title":"The usefulness of amyloid imaging in predicting the clinical outcome after two years in subjects with mild cognitive impairment","volume":"10","author":"GrimmerT","year":"2013","journal-title":"Current Alzheimer Research"},{"key":"10.1002\/14651858.CD010386.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jalz.2010.03.002","article-title":"The Alzheimer's Disease Neuroimaging Initiative: Annual change in biomarkers and clinical outcomes","volume":"3","author":"Beckett","year":"2010","journal-title":"Alzheimer's & Dementia"},{"key":"10.1002\/14651858.CD010386.pub2-BIB0007|cit7","doi-asserted-by":"crossref","unstructured":"Burns L Berman R Guo Z Soares H Kaplita S Yoo B The relationship between cerebral spinal fluid (CSF) biomarkers and Pittsburgh compound B (PIB) positron emission tomography (PET) in predicting Alzheimer's disease (AD) Alzheimer's & Dementia 2011 S206","DOI":"10.1016\/j.jalz.2011.05.579"},{"key":"10.1002\/14651858.CD010386.pub2-BIB0008|cit8","doi-asserted-by":"crossref","unstructured":"Ewers M Aisen P Jagust W Schuff N Weiner M Trojanowski J CSF biomarker and PIB-PET-derived beta-amyloid signature predicts brain metabolism grey matter and cognitive changes in non-demented subjects Alzheimer's & Dementia 2011 S102","DOI":"10.1093\/cercor\/bhr271"},{"key":"10.1002\/14651858.CD010386.pub2-BIB0009|cit9","doi-asserted-by":"crossref","unstructured":"Ishii K Sakata M Oda K Toyohara J Ishiwata K Senda M Age, ApoE e4, and ethnic effect on [C-11] PIB in multinational ADNI studies: Direct comparison of J-ADNI, US-ADNI and AIBL data Alzheimer's & Dementia 2011 S233","DOI":"10.1016\/j.jalz.2011.05.659"},{"key":"10.1002\/14651858.CD010386.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1093\/brain\/awp062","article-title":"Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence at pathological events in Alzheimer's disease","volume":"132","author":"Jack","year":"2009","journal-title":"Brain"},{"key":"10.1002\/14651858.CD010386.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1093\/brain\/awq277","article-title":"Brain beta-amyloid measures and magnetic resonance imaging athrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease","volume":"133","author":"Jack","year":"2010","journal-title":"Brain"},{"key":"10.1002\/14651858.CD010386.pub2-BIB0012|cit12","doi-asserted-by":"crossref","unstructured":"Landau S Petersen R Aisen P Jagust W Change in amyloid deposition is related to concurrent cognitive change in MCI Alzheimer's & Dementia 2011 S28","DOI":"10.1016\/j.jalz.2011.05.118"},{"key":"10.1002\/14651858.CD010386.pub2-BIB0013|cit13","doi-asserted-by":"crossref","unstructured":"Mormino EC Kluth JT Madison CM Rabinovici GD Baker SL Miller BL Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects Brain 2009 1310 23","DOI":"10.1093\/brain\/awn320"},{"key":"10.1002\/14651858.CD010386.pub2-BIB0014|cit14","unstructured":"Riddle WR Shokouhi S Donlevy SC Monitoring brain changes in mild cognitive impairment and a biomarker for structural changes and correlations with serial PET-FDG scans, PET-PIB scans, and MMSE scores European Journal of Neurology 2012 110"},{"key":"10.1002\/14651858.CD010386.pub2-BIB0015|cit15","doi-asserted-by":"crossref","unstructured":"Toledo JB Vanderstichele H Figurski M Aisen PS Petersen RC Weiner MW Factors affecting A plasma levels and their utility as biomarkers in ADNI Acta Neuropathologica 2011 401 13","DOI":"10.1007\/s00401-011-0861-8"},{"issue":"4","key":"10.1002\/14651858.CD010386.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/brain\/awr044","article-title":"Spatial patterns of brain amyloid-beta burden and atrophy rate associations in mild cognitive impairment","volume":"134","author":"Tosun","year":"2011","journal-title":"Brain"},{"key":"10.1002\/14651858.CD010386.pub2-BIB0017|cit17","doi-asserted-by":"crossref","unstructured":"Tosun D Schuff N Weiner M Predicting brain amyloid-b burden with atrophy in MCI Alzheimer's & Dementia 2011 S236","DOI":"10.1016\/j.jalz.2011.05.667"},{"key":"10.1002\/14651858.CD010386.pub2-BIB0018|cit18","doi-asserted-by":"crossref","unstructured":"Walhovd K B Fjell A M Brewer J McEvoy L Combining MR imaging, positron-emission tomography, and CSF biomarkers in the diagnosis and prognosis of Alzheimer disease American Journal of Neuroradiology 2010 347 54","DOI":"10.3174\/ajnr.A1809"},{"key":"10.1002\/14651858.CD010386.pub2-BIB0019|cit19","doi-asserted-by":"crossref","unstructured":"Koivunen J Karrasch M Scheinin NM Aalto S Vahlberg T Nagren K Cognitive decline and amyloid accumulation in patients with mild cognitive impairment Dementia and Geriatric Cognitive Disorders 2012 31 7","DOI":"10.1159\/000341580"},{"key":"10.1002\/14651858.CD010386.pub2-BIB0020|cit20","doi-asserted-by":"crossref","unstructured":"Koivunen J Pirttila T Kemppainen N Aalto S Herukka SK Jauhianen AM PET amyloid ligand [11C]PIB uptake and cerebrospinal fluid beta-amyloid in mild cognitive impairment Dementia and Geriatric Cognitive Disorders 2008 378 83","DOI":"10.1159\/000163927"},{"key":"10.1002\/14651858.CD010386.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1212\/WNL.0b013e318212015e","article-title":"Amyloid PET imaging in patients with mild cognitive impairment: A 2-year follow-up study","volume":"76","author":"Koivunen","year":"2011","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/14651858.CD010386.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s00259-012-2237-2","article-title":"A European multicentre PET study of fibrillar amyloid in Alzheimer's disease","volume":"40","author":"Nordberg","year":"2013","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"key":"10.1002\/14651858.CD010386.pub2-BIB0023|cit23","doi-asserted-by":"crossref","unstructured":"Nordberg A Carter SF Rinne J Drzezga A Brooks DJ Vandenberghe R A European multicentre PET study of fibrillar amyloid in Alzheimer's disease European Journal of Nuclear Medicine and Molecular Imaging 2013 104 14","DOI":"10.1007\/s00259-012-2237-2"},{"key":"10.1002\/14651858.CD010386.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1212\/WNL.0b013e3181b23564","article-title":"Conversion of amyloid positive and negative MCI to AD over 3 years","volume":"73","author":"Okello","year":"2009","journal-title":"Neurology"},{"issue":"6","key":"10.1002\/14651858.CD010386.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1007\/s00259-012-2102-3","article-title":"Longitudinal imaging of Alzheimer pathology using [11C]PIB, [18F]FDDNP and [18F]FDG PET","volume":"9","author":"Ossenkoppele","year":"2012","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"issue":"4","key":"10.1002\/14651858.CD010386.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.jalz.2012.07.003","article-title":"Impact of molecular imaging on the diagnostic process in a memory clinic","volume":"9","author":"Ossenkoppele","year":"2012","journal-title":"Alzheimer's & Dementia"},{"key":"10.1002\/14651858.CD010386.pub2-BIB0027|cit27","doi-asserted-by":"crossref","unstructured":"Villain N Chetelat G Grassiot B Bourgeat P Jones G Ellis KA Regional dynamics of amyloid-beta deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: A voxelwise PiB-PET longitudinal study Brain 2012 2126 39","DOI":"10.1093\/brain\/aws125"},{"key":"10.1002\/14651858.CD010386.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/ana.22248","article-title":"Longitudinal assessment of A\u03b2 and cognition in a Alzheimer disease","volume":"69","author":"Villemagne","year":"2011","journal-title":"Annals of \u00a0Neurology"},{"key":"10.1002\/14651858.CD010386.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/ana.21598","article-title":"Amyloid imaging in mild cognitive impairment subtypes","volume":"65","author":"Wolk","year":"2009","journal-title":"Annals of Neurology"},{"key":"10.1002\/14651858.CD010386.pub2-BIB0030|cit30","unstructured":"Choo H Lee DY Seo EH Kim YK Yoon EJ Lee DS PIB retention changes in cognitively normal, mild cognitive impairment and Alzheimer's disease: One year follow-up study IL Alzheimer's & Dementia 2011 S208 9"},{"key":"10.1002\/14651858.CD010386.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1016\/j.neurobiolaging.2009.12.008","article-title":"Lack of association between 11C-PIB longitudinal brain atrophy in non-demented older individuals","volume":"32","author":"Driscoll","year":"2011","journal-title":"Neurobiology of Aging"},{"key":"10.1002\/14651858.CD010386.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jalz.2010.03.009","article-title":"addressing population aging and Al;zheimer's disease through the Australian imaging biomarkers and lifestyle study: collaboration with the Alzheimer's Disease Neuroimaging Initiative","volume":"6","author":"Ellis","year":"2010","journal-title":"Alzheimer's & Dementia"},{"key":"10.1002\/14651858.CD010386.pub2-BIB0033|cit33","doi-asserted-by":"crossref","unstructured":"Fagan AM Roe CM Xiong C Mintun M Cerebrospinal fluid tau\/beta-amyloid<sub>42<\/sub> ratio as a prediction of cognitive decline in nondemented older adults Archives of Neurology 2007 343 9","DOI":"10.1001\/archneur.64.3.noc60123"},{"key":"10.1002\/14651858.CD010386.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"198.e1","DOI":"10.1016\/j.neurobiolaging.2010.06.015","article-title":"Dynamic changes in PET amyloid and FDG imaging at diffetrent stages of Alzheimer's disease","volume":"33","author":"Kadir","year":"2012","journal-title":"Neurobiology of Aging"},{"key":"10.1002\/14651858.CD010386.pub2-BIB0035|cit35","doi-asserted-by":"crossref","unstructured":"Kadir A Almkvist O Forsberg A Wall A Engler H Langstrom B Dynamic changes in PET amyloid and FDG imaging at different stages of Alzheimer's disease Neurobiology of Aging 2012 198.e1 14","DOI":"10.1016\/j.neurobiolaging.2010.06.015"},{"issue":"10","key":"10.1002\/14651858.CD010386.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1212\/WNL.0b013e3181d3e3e9","article-title":"Longitudinal cognitive decline is associated with fibrillar amyloid-beta measured by 11C-PIB","volume":"74","author":"Resnick","year":"2010","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD010386.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.neurobiolaging.2010.04.007","article-title":"Amyloid imaging results from the Australian Imaging Biomarkers and Lifestyle (AIBL) study of aging","volume":"31","author":"Rowe","year":"2010","journal-title":"Neurobiology of Aging"},{"key":"10.1002\/14651858.CD010386.pub2-BIB0038|cit38","doi-asserted-by":"crossref","unstructured":"Shinotoh H Shimada H Hirano S Tanaka N Sato K Kiyoshi F Longitudinal [11C]PIB PET study in healthy elderly persons, patients with mild cognitive impairment, and Alzheimer's disease Alzheimer's & Dementia 2011 S224","DOI":"10.1016\/j.jalz.2011.05.628"},{"key":"10.1002\/14651858.CD010386.pub2-BIB0039|cit39","doi-asserted-by":"crossref","unstructured":"Sojkova J Beason-Held L Zhou Y An Y Kraut MA Longitudinal cerebral blood flow and amyloid deposition: An emerging pattern? Journal of Nuclear Medicine 2008 1465 71","DOI":"10.2967\/jnumed.108.051946"},{"issue":"5","key":"10.1002\/14651858.CD010386.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1001\/archneurol.2011.77","article-title":"Longitudinal patterns of beta-amyloid deposition in nondemented older adults","volume":"68","author":"Sojkova","year":"2011","journal-title":"Archives of Neurology"},{"key":"10.1002\/14651858.CD010386.pub2-BIB0041|cit41","unstructured":"Dekosky ST Mathis CA Price JC Lopresti BJ Meltzer CC Ziolko SK Human amyloid-imaging studies with Pittsburgh compound-B in mild cognitive impairment (MCI): Is MCI the critical period of amyloid plaque deposition? Neurology 2006 A60"},{"issue":"3","key":"10.1002\/14651858.CD010386.pub2-BIB0042|cit42","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimer\u2019s & Dementia"},{"issue":"6","key":"10.1002\/14651858.CD010386.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"887","DOI":"10.2967\/jnumed.112.112599","article-title":"Assessing mild cognitive impairment with amyloid and dopamine terminal molecular imaging","volume":"54","author":"Albin","year":"2013","journal-title":"Journal of Nuclear Medicine"},{"issue":"3","key":"10.1002\/14651858.CD010386.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1001\/archneur.64.3.431","article-title":"Molecular imaging with Pittsburgh compound B confirmed at autopsy: a case report","volume":"64","author":"Bacskai","year":"2007","journal-title":"Archives of Neurology"},{"issue":"3","key":"10.1002\/14651858.CD010386.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"238-44. doi:10.","DOI":"10.1097\/MNM.0000000000000042","article-title":"Amyloid imaging with (11)C-PIB PET\/CT and glucose metabolism with (18)F-FDG PET\/CT in a study on cognitive impairment in the clinical setting","volume":"35","author":"Banzo","year":"2014","journal-title":"Nuclear Medicine Communications"},{"issue":"1","key":"10.1002\/14651858.CD010386.pub2-BIB0046|cit46","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005593","article-title":"Cholinesterase inhibitors for Alzheimer's disease","author":"Birks","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD010386.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"189-201. doi: 1","DOI":"10.1038\/npp.2013.154","article-title":"Biomarkers in amyloid-\u03b2 immunotherapy trials in Alzheimer's disease","volume":"39","author":"Blennow","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD010386.pub2-BIB0048|cit48","unstructured":"Bossuyt PM Leeflang MM Chapter 6: Developing criteria for including studies Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy Version 0.4 2008"},{"key":"10.1002\/14651858.CD010386.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/01.wad.0000183086.99691.91","article-title":"Clinical features of frontotemporal dementia","volume":"19 Suppl 1","author":"Boxer","year":"2005","journal-title":"Alzheimer's Disease and Associated Disorders"},{"key":"10.1002\/14651858.CD010386.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1136\/jnnp.57.4.416","article-title":"Clinical and neuropathological criteria for frontotemporal dementia. The Land and Manchester Group","volume":"57","author":"Brun","year":"1994","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"10.1002\/14651858.CD010386.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1017\/S1041610204000092","article-title":"Is MCI really just early dementia? A systematic review of conversion studies","volume":"16","author":"Bruscoli","year":"2004","journal-title":"International Psychogeriatrics"},{"key":"10.1002\/14651858.CD010386.pub2-BIB0052|cit52","first-page":"doi:10.1111\/ene","article-title":"Pittsburgh compound B retention and progression of cognitive status - a meta-analysis","author":"Chen","year":"2014","journal-title":"European Journal of Neurology"},{"issue":"14","key":"10.1002\/14651858.CD010386.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"6222","DOI":"10.1073\/pnas.0914904107","article-title":"Specific estrogen sulfotransferase (SULT1E1) substrates and molecular imaging probe candidates","volume":"107","author":"Cole GB. Keum","year":"2010","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"10.1002\/14651858.CD010386.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0197-4580(92)90027-U","article-title":"Identification of normal and pathological aging in prospectively studied nondemented elderly humans","volume":"13","author":"Dickson","year":"1992","journal-title":"Neurobiology of Aging"},{"key":"10.1002\/14651858.CD010386.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1007\/s00259-007-0697-6","article-title":"Basic pathologies of neurodegenerative dementias and their relevance for state-of-the-art molecular imaging studies","volume":"35","author":"Drzezga","year":"2008","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"key":"10.1002\/14651858.CD010386.pub2-BIB0056|cit56","unstructured":"American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders. 3rd revised edition Washington, DC: American Psychiatric Association 1987"},{"key":"10.1002\/14651858.CD010386.pub2-BIB0057|cit57","unstructured":"American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders. 4th edition Washington, DC: American Psychiatric Association 1994"},{"issue":"11","key":"10.1002\/14651858.CD010386.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/S1474-4422(10)70223-4","article-title":"Revising the definition of Alzheimer's disease: a new lexicon","volume":"9","author":"Dubois","year":"2010","journal-title":"Lancet Neurology"},{"issue":"7","key":"10.1002\/14651858.CD010386.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1001\/jamaneurol.2013.420","article-title":"Does a positive Pittsburgh compound B scan in a patient with dementia equal Alzheimer disease?","volume":"70","author":"Ducharme","year":"2013","journal-title":"JAMA Neurology"},{"key":"10.1002\/14651858.CD010386.pub2-BIB0060|cit60","doi-asserted-by":"crossref","unstructured":"Ellis KA Rowe C Masters C Szoeke C Taddei K Martins R Predictors of cognitive decline at 18 month follow up among 1112 participants in the australian imaging, biomarkers and lifestyle flagship study of ageing (AIBL) Alzheimer's & Dementia 2011 S158","DOI":"10.1016\/j.jalz.2011.05.426"},{"issue":"1","key":"10.1002\/14651858.CD010386.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s00259-007-0523-1","article-title":"In vivo amyloid imaging with PET in frontotemporal dementia","volume":"35","author":"Engler","year":"2008","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"issue":"3","key":"10.1002\/14651858.CD010386.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"769","DOI":"10.3233\/JAD-122002","article-title":"A longitudinal follow-up of 550 mild cognitive impairment patients: evidence for large conversion to dementia rates and detection of major risk factors involved","volume":"34","author":"Espinosa","year":"2013","journal-title":"Journal of Alzheimer's Disease"},{"issue":"6","key":"10.1002\/14651858.CD010386.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"952-62. doi:10.","DOI":"10.1002\/ana.20873","article-title":"Frontotemporal dementia: clinicopathological correlations","volume":"59","author":"Forman","year":"2006","journal-title":"Annals of Neurology"},{"issue":"15","key":"10.1002\/14651858.CD010386.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1002\/mds.23393","article-title":"Amyloid imaging of Lewy body-associated disorders","volume":"25","author":"Foster ER. Campbell","year":"2010","journal-title":"Movement Disorders"},{"issue":"16","key":"10.1002\/14651858.CD010386.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"1596-8. doi:10.","DOI":"10.1001\/jama.2014.3891","article-title":"Researchers test strategies to prevent Alzheimer disease","volume":"311","author":"Friedrich","year":"2014","journal-title":"JAMA"},{"issue":"5-6","key":"10.1002\/14651858.CD010386.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1159\/000084709","article-title":"Mild cognitive impairment: an operational definition and its conversion rate to Alzheimer's disease","volume":"19","author":"Geslani","year":"2005","journal-title":"Dementia and Geriatric Cognitive Disorders"},{"issue":"8","key":"10.1002\/14651858.CD010386.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/mds.25048","article-title":"Brain amyloid and cognition in Lewy body diseases","volume":"27","author":"Gomperts","year":"2012","journal-title":"Movement Disorders"},{"issue":"1","key":"10.1002\/14651858.CD010386.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1212\/WNL.0b013e31827b1a07","article-title":"Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia","volume":"801","author":"Gomperts","year":"2013","journal-title":"Neurology"},{"issue":"4","key":"10.1002\/14651858.CD010386.pub2-BIB0069|cit69","first-page":"312-36. doi:10.","article-title":"Development of biomarkers to chart all Alzheimer's disease stages: the royal road to cutting the therapeutic Gordian knot","volume":"8","author":"Hampe","year":"2012","journal-title":"Alzheimer's & Dementia"},{"key":"10.1002\/14651858.CD010386.pub2-BIB0070|cit70","unstructured":"Hatashita S Yamasaki H PET biomarkers of beta-amyloid deposition and neuronal injury in mild cognitive impairment due to Alzheimer's disease European Journal of Nuclear Medicine and Molecular Imaging 2012 S407"},{"issue":"10","key":"10.1002\/14651858.CD010386.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"e47739. doi:10.","DOI":"10.1371\/journal.pone.0047739","article-title":"Enrichment and stratification for predementia Alzheimer disease clinical trials","volume":"7","author":"Holland","year":"2012","journal-title":"PLoS One"},{"key":"10.1002\/14651858.CD010386.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/brain\/awm336","article-title":"11CPIB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment","volume":"131","author":"Jack","year":"2008","journal-title":"Brain"},{"key":"10.1002\/14651858.CD010386.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/ana.21164","article-title":"Imaging of amyloid burden and distribution in cerebral amyloid angiopathy","volume":"62","author":"Johnson","year":"2007","journal-title":"Annals of Neurology"},{"issue":"4","key":"10.1002\/14651858.CD010386.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"e106-9. doi:10.","DOI":"10.1016\/j.jalz.2013.06.001","article-title":"Update on appropriate use criteria for amyloid PET imaging: dementia experts, mild cognitive impairment, and education. Amyloid Imaging Task Force of the Alzheimer's Association and Society for Nuclear Medicine and Molecular Imaging","volume":"9","author":"Johnson","year":"2013","journal-title":"Alzheimer's & Dementia"},{"issue":"2","key":"10.1002\/14651858.CD010386.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"283-9. doi:10.1","DOI":"10.1007\/s00259-013-2562-0","article-title":"Five-year follow-up of 11C-PIB uptake in Alzheimer's disease and MCI","volume":"41","author":"Kemppainen","year":"2014","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"issue":"3","key":"10.1002\/14651858.CD010386.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/ana.20009","article-title":"Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B","volume":"55","author":"Klunk","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1002\/14651858.CD010386.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1136\/bmj.324.7335.477","article-title":"Evaluation of diagnostic procedures","volume":"324","author":"Knotnerus","year":"2002","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD010386.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1373\/clinchem.2007.096032","article-title":"Bias in sensitivity and specificity caused by data-driven selection of optimal cutoff values: mechanisms, magnitude, and solutions","volume":"54","author":"Leeflang","year":"2008","journal-title":"Clinical Chemistry"},{"issue":"10","key":"10.1002\/14651858.CD010386.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1001\/archneur.65.10.noc80013","article-title":"Assessment of beta-amyloid in a frontal cortical brain biopsy specimen and by positron emission tomography with carbon 11-labeled Pittsburgh compound B","volume":"65","author":"Leinonen","year":"2008","journal-title":"Archives of Neurology"},{"key":"10.1002\/14651858.CD010386.pub2-BIB0080|cit80","doi-asserted-by":"crossref","unstructured":"Maruff P Ellis K Harrington K Gale J Fredrickson A Darby D Determining rate of decline in prealzheimer's and Alzheimer's disease AIBL participants using a regular brief cognitive assessment Alzheimer's & Dementia 2011 S255","DOI":"10.1016\/j.jalz.2011.05.724"},{"issue":"21","key":"10.1002\/14651858.CD010386.pub2-BIB0081|cit81","first-page":"12245","article-title":"Beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease","volume":"98","author":"Masliah","year":"2001","journal-title":"Proceedings of the National Academy of the Sciences of the United States of America"},{"issue":"8","key":"10.1002\/14651858.CD010386.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1111\/j.1532-5415.2008.01820.x","article-title":"Two-year progression from mild cognitive impairment to dementia: to what extent do different definitions agree?","volume":"56","author":"Matthews","year":"2008","journal-title":"Journal of the American Geriatrics Society"},{"issue":"4","key":"10.1002\/14651858.CD010386.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1001\/jama.2009.1064","article-title":"CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment","volume":"302","author":"Mattsson","year":"2009","journal-title":"JAMA"},{"issue":"5","key":"10.1002\/14651858.CD010386.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1212\/WNL.47.5.1113","article-title":"Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB international workshop","volume":"47","author":"McKeith","year":"1996","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD010386.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","article-title":"Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium","volume":"65","author":"McKeith","year":"2005","journal-title":"Neurology"},{"issue":"7","key":"10.1002\/14651858.CD010386.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD010386.pub2-BIB0087|cit87","doi-asserted-by":"crossref","unstructured":"McKhann GM Knopman DS Chertkow H Hyman BT Clifford RJ Kawas CH The diagnosis of dementia due to Alzheimer\u2019s disease: recommendation from the National Institute on Ageing and Alzheimer\u2019s Association workgroup Alzheimer\u2019s & Dementia 2011 263 9","DOI":"10.1016\/j.jalz.2011.03.005"},{"issue":"2","key":"10.1002\/14651858.CD010386.pub2-BIB0088|cit88","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003154.pub5","article-title":"Memantine for dementia","author":"McShane","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD010386.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1212\/WNL.41.4.479","article-title":"The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease","volume":"41","author":"Mirra","year":"1991","journal-title":"Neurology"},{"issue":"4","key":"10.1002\/14651858.CD010386.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1600-0447.2008.01326.x","article-title":"Rate of progression of mild cognitive impairment to dementia--meta-analysis of 41 robust inception cohort studies","volume":"119","author":"Mitchell","year":"2009","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD010386.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1212\/WNL.43.11.2412-a","article-title":"The Clinical Dementia Rating (CDR): current version and scoring rules","volume":"43","author":"Morris","year":"1993","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD010386.pub2-BIB0092|cit92","doi-asserted-by":"crossref","unstructured":"Mosconi L Matthews D Schmidt M Andrews R Characterizing brain amyloid changes using PIB-PET: Progression, clinical correlates, PIB status and optimized sampling Alzheimer's & Dementia 2012","DOI":"10.1016\/j.jalz.2012.05.935"},{"key":"10.1002\/14651858.CD010386.pub2-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1212\/WNL.51.6.1546","article-title":"Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria","volume":"51","author":"Neary","year":"1998","journal-title":"Neurology"},{"issue":"11","key":"10.1002\/14651858.CD010386.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1097\/00005072-199911000-00004","article-title":"Application of the National Institute on Aging (NIA)-Reagan Institute criteria for the neuropathological diagnosis of Alzheimer disease","volume":"58","author":"Newell","year":"1999","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"issue":"3","key":"10.1002\/14651858.CD010386.pub2-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.neuron.2004.07.003","article-title":"Abeta immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome","volume":"43","author":"Oddo","year":"2004","journal-title":"Neuron"},{"key":"10.1002\/14651858.CD010386.pub2-BIB0096|cit96","doi-asserted-by":"crossref","unstructured":"Okello A Edison P Archer H Hinz R Fox N Kennedy A Amyloid deposition and cerebral glucose metabolism in mild cognitive impairment: a longitudinal 11c-PIB and 18f-FDG PET study Journal of Neurology, Neurosurgery, and Psychiatry 2007 219 20","DOI":"10.1016\/j.jalz.2006.05.958"},{"key":"10.1002\/14651858.CD010386.pub2-BIB0097|cit97","doi-asserted-by":"crossref","unstructured":"Perrotin A Desgranges B Duval C La Joie R Mezenge F Landeau B The imap project: How does the awareness of memory deficits evolve in the course of Alzheimer's disease? Insights from its relationships to PET b-amyloid and metabolism measurements Alzheimer's & Dementia 2011 S742 3","DOI":"10.1016\/j.jalz.2011.05.185"},{"key":"10.1002\/14651858.CD010386.pub2-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1001\/archneur.56.3.303","article-title":"Mild cognitive impairment: clinical characterization and outcome","volume":"56","author":"Petersen","year":"1999","journal-title":"Archives of Neurology"},{"key":"10.1002\/14651858.CD010386.pub2-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2796.2004.01388.x","article-title":"Mild cognitive impairment as a diagnostic entity","volume":"256","author":"Petersen","year":"2004","journal-title":"Journal of Internal Medicine"},{"key":"10.1002\/14651858.CD010386.pub2-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1001\/archneurol.2009.266","article-title":"Mild cognitive impairment: ten years later","volume":"66","author":"Petersen","year":"2009","journal-title":"Archives of Neurology"},{"key":"10.1002\/14651858.CD010386.pub2-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1038\/sj.jcbfm.9600146","article-title":"Kinetic modelling of amyloid binding in humans using PET imaging and Pittsburgh compound-B","volume":"25","author":"Price","year":"2005","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"issue":"Issue 4. Art. N","key":"10.1002\/14651858.CD010386.pub2-BIB0102|cit102","article-title":"Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the diagnosis of dementia within community dwelling populations","author":"Quinn","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"15","key":"10.1002\/14651858.CD010386.pub2-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1212\/01.wnl.0000259035.98480.ed","article-title":"11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration","volume":"68","author":"Rabinovici","year":"2007","journal-title":"Neurology"},{"issue":"23","key":"10.1002\/14651858.CD010386.pub2-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1212\/WNL.0b013e31823b9c5e","article-title":"Amyloid vs FDG-PET in the differential diagnosis of AD and FTLD","volume":"77","author":"Rabinovici","year":"2011","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD010386.pub2-BIB0105|cit105","doi-asserted-by":"crossref","unstructured":"Rentz D Betensky R Becker A England R Maye J Gidicsin C Amyloid deposition in non-demented elderly predicts longitudinal cognitive decline Alzheimer's & Dementia 2011 S221","DOI":"10.1016\/j.jalz.2011.05.621"},{"issue":"4","key":"10.1002\/14651858.CD010386.pub2-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"363-72. doi:10.","DOI":"10.1016\/S1474-4422(10)70043-0","article-title":"11C-PiB PET assessment of change in fibrillar amyloid-beta load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study","volume":"9","author":"Rinne","year":"2010","journal-title":"Lancet Neurology"},{"issue":"2","key":"10.1002\/14651858.CD010386.pub2-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1212\/WNL.43.2.250","article-title":"Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop","volume":"43","author":"Roman","year":"1993","journal-title":"Neurology"},{"issue":"20","key":"10.1002\/14651858.CD010386.pub2-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1212\/01.wnl.0000261919.22630.ea","article-title":"Imaging beta-amyloid burden in aging and dementia","volume":"68","author":"Rowe","year":"2007","journal-title":"Neurology"},{"issue":"3","key":"10.1002\/14651858.CD010386.pub2-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"541-9. doi:10.3","DOI":"10.3233\/JAD-131733","article-title":"The temporospatial evolution of neuritic plaque-related and independent tauopathies: implications for dementia staging","volume":"40","author":"Royall","year":"2014","journal-title":"Journal of Alzheimer's Disease"},{"key":"10.1002\/14651858.CD010386.pub2-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1002\/sim.942","article-title":"A hierarchical regression approach to meta-analysis of diagnostic test accuracy evaluations","volume":"20","author":"Rutter","year":"2001","journal-title":"Statistics in Medicine"},{"issue":"4","key":"10.1002\/14651858.CD010386.pub2-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"322-33. doi:10.","DOI":"10.1056\/NEJMoa1304839","article-title":"Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease","volume":"370","author":"Salloway","year":"2014","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD010386.pub2-BIB0112|cit112","article-title":"SAS\/OR\u00ae 9.3 User\u2019s Guide: Mathematical Programming. Cary, NC: SAS Institute Inc. SAS\/OR\u00ae 9.3 User\u2019s Guide: Mathematical Programming Copyright \u00a9 2011","author":"SAS Institute Inc. 2011","journal-title":"SAS Institute Inc., Cary, NC, USA http:\/\/support.sas.com\/documentation\/cdl\/en\/ormpug\/63975\/PDF\/default\/ormpug.pdf"},{"issue":"22","key":"10.1002\/14651858.CD010386.pub2-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJMoa0806142","article-title":"Age, neuropathology, and dementia","volume":"360","author":"Savva","year":"2009","journal-title":"New England Journal of Medicine"},{"issue":"24","key":"10.1002\/14651858.CD010386.pub2-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"2197-204. doi:0","DOI":"10.1212\/01.wnl.0000271090.28148.24","article-title":"Mixed brain pathologies account for most dementia cases in community-dwelling older persons","volume":"69","author":"Schneider","year":"2007","journal-title":"Neurology"},{"issue":"2","key":"10.1002\/14651858.CD010386.pub2-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"200-8. doi:10.1","DOI":"10.1002\/ana.21706","article-title":"The neuropathology of probable Alzheimer disease and mild cognitive impairment","volume":"66","author":"Schneider","year":"2009","journal-title":"Annals of Neurology"},{"issue":"12","key":"10.1002\/14651858.CD010386.pub2-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"1182-92. doi:10","DOI":"10.1097\/NEN.0000000000000016","article-title":"Examination of the clinicopathologic continuum of Alzheimer disease in the autopsy cohort of the National Alzheimer Coordinating Center","volume":"72","author":"Serrano-Pozo","year":"2013","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"issue":"2","key":"10.1002\/14651858.CD010386.pub2-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/mds.25286","article-title":"Beta-amyloid in Lewy body disease is related to Alzheimer's disease-like atrophy","volume":"28","author":"Shimada","year":"2013","journal-title":"Movement Disorders"},{"issue":"2","key":"10.1002\/14651858.CD010386.pub2-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.neuroimage.2010.04.013","article-title":"Voxel-based analysis of Alzheimer's disease PET imaging using a triplet of radiotracers: PIB, FDDNP, and FDG","volume":"52","author":"Shin","year":"2010","journal-title":"NeuroImage"},{"key":"10.1002\/14651858.CD010386.pub2-BIB0119|cit119","first-page":"doi:10.4061\/201","article-title":"Multimodal imaging of Alzheimer pathophysiology in the brain's default mode network","author":"Shin","year":"2011","journal-title":"International Journal of Alzheimer's Disease"},{"key":"10.1002\/14651858.CD010386.pub2-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2011.03.003","article-title":"Toward defining the preclinical stages of Alzheimer\u2019s disease: recommendation from the National Institute on Ageing-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimer\u2019s & Dementia"},{"issue":"1","key":"10.1002\/14651858.CD010386.pub2-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"143-51. doi:10.","DOI":"10.1016\/j.neurobiolaging.2013.06.018","article-title":"Comparison of neuroimaging modalities for the prediction of conversion from mild cognitive impairment to Alzheimer's dementia","volume":"35","author":"Trzepacz","year":"2014","journal-title":"Neurobiology of Aging"},{"key":"10.1002\/14651858.CD010386.pub2-BIB0122|cit122","doi-asserted-by":"crossref","unstructured":"Villain N Chetelat G Grassiot B Bourgeat P Jones G Ellis K Dynamic of beta-amyloid deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: A PIB-PET longitudinal study Alzheimer's & Dementia 2011 S226 7","DOI":"10.1016\/j.jalz.2011.05.636"},{"key":"10.1002\/14651858.CD010386.pub2-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/j.neuropsychologia.2008.02.008","article-title":"A\u00e2 deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer\u2019s disease","volume":"46","author":"Villemagne","year":"2008","journal-title":"Neuropsychologia"},{"key":"10.1002\/14651858.CD010386.pub2-BIB0124|cit124","doi-asserted-by":"crossref","unstructured":"Villemagne V Ellis K Chetelat G Bourgeat P Jones G Martins R AB accumulation correlates with cognitive decline: Results from the longitudinal aibl study Alzheimer's & Dementia 2011 S39","DOI":"10.1016\/j.jalz.2011.05.142"},{"issue":"7","key":"10.1002\/14651858.CD010386.pub2-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1212\/01.wnl.0000238517.59286.c5","article-title":"Ten-year risk of dementia in subjects with mild cognitive impairment","volume":"67","author":"Visser","year":"2006","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD010386.pub2-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Annals of Internal Medicine"},{"issue":"3","key":"10.1002\/14651858.CD010386.pub2-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1365-2796.2004.01380.x","article-title":"Mild cognitive impairment - beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment","volume":"256","author":"Winblad","year":"2004","journal-title":"Journal of Internal Medicine"},{"issue":"5","key":"10.1002\/14651858.CD010386.pub2-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/ana.21598","article-title":"Amyloid imaging in mild cognitive impairment subtypes","volume":"65","author":"Wolk","year":"2009","journal-title":"Annals of Neurology"},{"key":"10.1002\/14651858.CD010386.pub2-BIB0129|cit129","article-title":"Mental Health. Alzheimer\u2019s Disease","author":"World Health Organization","journal-title":"http:\/\/ www.afro.who.int\/mentalhealth\/related_disease\/alyheimer_disease.html. Last updated 18 September 2002"},{"key":"10.1002\/14651858.CD010386.pub2-BIB0130|cit130","unstructured":"World Health Organization International Statistical Classification of Diseases and Related Health Problems (ICD-10 Version: 2010) http:\/\/apps.who.int\/classifications\/icd10\/browse\/2010\/en"},{"issue":"2","key":"10.1002\/14651858.CD010386.pub2-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"185-98. doi:10.","DOI":"10.1111\/j.1742-1241.2011.02845.x","article-title":"Diagnostic accuracy of 18 F-FDG and 11 C-PIB-PET for prediction of short-term conversion to Alzheimer's disease in subjects with mild cognitive impairment","volume":"66","author":"Zhang","year":"2012","journal-title":"International Journal of Clinical Practice"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD010386.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T18:30:02Z","timestamp":1746297002000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD010386.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Dementia and Cognitive Improvement Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,7,23]]},"references-count":131,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2014,7]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd010386.pub2","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718504055.793497968","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,23]]}}}